TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,573,288 | -27.2% | 144,648 | -37.7% | 0.01% | -26.7% |
| Q1 2024 | $3,533,998 | -40.2% | 232,347 | -32.9% | 0.02% | -46.4% |
| Q4 2023 | $5,913,164 | -27.3% | 346,204 | +5.7% | 0.03% | -31.7% |
| Q2 2023 | $8,137,733 | +1014.8% | 327,606 | +1641.2% | 0.04% | +925.0% |
| Q2 2021 | $730,000 | -42.7% | 18,815 | -23.3% | 0.00% | -50.0% |
| Q4 2020 | $1,275,000 | +222.8% | 24,516 | -38.9% | 0.01% | +100.0% |
| Q1 2020 | $395,000 | – | 40,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 10,451,241 | $157,186,665 | 42.99% |
| M28 Capital Management LP | 339,500 | $5,106,080 | 5.77% |
| Ghost Tree Capital, LLC | 1,100,000 | $16,544,000 | 4.89% |
| Soleus Capital Management, L.P. | 750,300 | $11,284,512 | 1.17% |
| Parkman Healthcare Partners LLC | 275,641 | $4,145,641 | 0.90% |
| 683 Capital Management, LLC | 775,000 | $11,656,000 | 0.87% |
| Leucadia National | 5,100,110 | $76,705,654 | 0.62% |
| Pier Capital, LLC | 233,472 | $3,511,419 | 0.53% |
| Harvest Investment Services, LLC | 40,729 | $612,564 | 0.47% |
| Artal Group S.A. | 511,389 | $7,691 | 0.46% |